依然飞飞 personal page - To The Moon

依然飞飞

依然飞飞

No personal profile

139Follow

1Followers

0Topic

0Badge

2021-08-24

Good

Sorry, the original content has been removed

2021-08-20

Nice

Sorry, the original content has been removed

2021-08-20

Giid

Sorry, the original content has been removed

2021-08-15

Good

Chasing Tesla: Here are the current electric vehicle plans of every major car maker

01-14

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good

01-09

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

01-05

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good

01-03

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

01-01

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

2021-09-07

Good

@依然飞飞:Good

2021-08-13

$XIAOMI-W(01810)$ggood

01-08

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good

01-07

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

01-06

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

01-04

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good

01-02

Good good$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$

2023-12-31

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

2023-12-29

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good

2023-12-26

$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good hood

2023-11-06

$FRANKLIN TECHNOLOGY "A" (HKD) ACC(LU0889565833.HKD)$ good good

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4091812603387580,"uuid":"4091812603387580","gmtCreate":1628723315908,"gmtModify":1628833315585,"name":"依然飞飞","pinyin":"yrffyiranfeifei","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":139,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.54%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":262712390664240,"gmtCreate":1705172953608,"gmtModify":1705172955314,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/262712390664240","isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":262338605670624,"gmtCreate":1705081556530,"gmtModify":1705081558437,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/262338605670624","isVote":1,"tweetType":1,"viewCount":71,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":262003291193352,"gmtCreate":1705000535507,"gmtModify":1705000538409,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/262003291193352","isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":261904710983848,"gmtCreate":1704960333591,"gmtModify":1704960335174,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261904710983848","isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":261903844036784,"gmtCreate":1704960297187,"gmtModify":1704960300675,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261903844036784","isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":261405403468008,"gmtCreate":1704830166568,"gmtModify":1704830168433,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261405403468008","isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":261024401531064,"gmtCreate":1704737143861,"gmtModify":1704737145573,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261024401531064","isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":260648139239440,"gmtCreate":1704645312299,"gmtModify":1704645315778,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/260648139239440","isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":260353514410184,"gmtCreate":1704573232252,"gmtModify":1704573234105,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/260353514410184","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259985368051992,"gmtCreate":1704483354410,"gmtModify":1704483356628,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259985368051992","isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259644330790968,"gmtCreate":1704400075658,"gmtModify":1704400077337,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259644330790968","isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259264782303448,"gmtCreate":1704309676391,"gmtModify":1704309679670,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259264782303448","isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258833485152320,"gmtCreate":1704225653531,"gmtModify":1704225656857,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"okok","listText":"okok","text":"okok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258833485152320","repostId":"248312805347464","repostType":1,"repost":{"id":248312805347464,"gmtCreate":1701660745864,"gmtModify":1703059991513,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/61ed9b39c6cbcdce6372edc1c0b48a2d","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"🐅🌟 TIGER TYCOON CHALLENGE IS ON! 🌟🐅","htmlText":"Hey Tycoons! 🎩💼 Ready to embark on the adventure of a lifetime? Introducing the Tiger Tycoon Challenge – where fortunes are made, and USD 888 worth of prizes await the boldest players! 🏰🌈🎯 Objective: Build your empire, score big points, and unlock fabulous rewards!💰 Gold Rush: Grab those shiny gold coins every time you pass by it! Cha-ching! 💰💵🏠 Construct &amp; Conquer: Step on an empty tile to construct a building to gain points! 🏰🏆 Prizes Galore: Hit the prize tile to claim your treasure – it could be anything! 🎁✨🔄 Lucky Draw: Land on the draw tile and brace yourself! You might move forward, backward, or even unlock a secret power! 🔄🔮🚀 Airdrop Alert: Keep your eyes on the sky! Periodically, the Tiger Tycoon map will rain down special rewards like stocks, vouchers, and more. Fastest finge","listText":"Hey Tycoons! 🎩💼 Ready to embark on the adventure of a lifetime? Introducing the Tiger Tycoon Challenge – where fortunes are made, and USD 888 worth of prizes await the boldest players! 🏰🌈🎯 Objective: Build your empire, score big points, and unlock fabulous rewards!💰 Gold Rush: Grab those shiny gold coins every time you pass by it! Cha-ching! 💰💵🏠 Construct &amp; Conquer: Step on an empty tile to construct a building to gain points! 🏰🏆 Prizes Galore: Hit the prize tile to claim your treasure – it could be anything! 🎁✨🔄 Lucky Draw: Land on the draw tile and brace yourself! You might move forward, backward, or even unlock a secret power! 🔄🔮🚀 Airdrop Alert: Keep your eyes on the sky! Periodically, the Tiger Tycoon map will rain down special rewards like stocks, vouchers, and more. Fastest finge","text":"Hey Tycoons! 🎩💼 Ready to embark on the adventure of a lifetime? Introducing the Tiger Tycoon Challenge – where fortunes are made, and USD 888 worth of prizes await the boldest players! 🏰🌈🎯 Objective: Build your empire, score big points, and unlock fabulous rewards!💰 Gold Rush: Grab those shiny gold coins every time you pass by it! Cha-ching! 💰💵🏠 Construct & Conquer: Step on an empty tile to construct a building to gain points! 🏰🏆 Prizes Galore: Hit the prize tile to claim your treasure – it could be anything! 🎁✨🔄 Lucky Draw: Land on the draw tile and brace yourself! You might move forward, backward, or even unlock a secret power! 🔄🔮🚀 Airdrop Alert: Keep your eyes on the sky! Periodically, the Tiger Tycoon map will rain down special rewards like stocks, vouchers, and more. Fastest finge","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/248312805347464","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258833013289008,"gmtCreate":1704225644605,"gmtModify":1704225646330,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258833013289008","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258466262950160,"gmtCreate":1704136016885,"gmtModify":1704136019376,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good good<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>","listText":"Good good<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>","text":"Good good$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258466262950160","isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258113661378616,"gmtCreate":1704050064517,"gmtModify":1704050067598,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258113661378616","isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":257758733312264,"gmtCreate":1703963279552,"gmtModify":1703963281127,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/257758733312264","isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":257409570500624,"gmtCreate":1703878148072,"gmtModify":1703878149608,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/257409570500624","isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":257054581284960,"gmtCreate":1703791361988,"gmtModify":1703791363831,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/257054581284960","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":256732915335432,"gmtCreate":1703712835710,"gmtModify":1703712838168,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good hood","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good hood","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good hood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256732915335432","isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":834658219,"gmtCreate":1629800384931,"gmtModify":1676530135097,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":9,"repostSize":4,"link":"https://ttm.financial/post/834658219","repostId":"1186636161","repostType":4,"isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838442430,"gmtCreate":1629426103120,"gmtModify":1676530037047,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/838442430","repostId":"1178264141","repostType":4,"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838448460,"gmtCreate":1629425991150,"gmtModify":1676530037001,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Giid","listText":"Giid","text":"Giid","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/838448460","repostId":"1134893598","repostType":4,"isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897429690,"gmtCreate":1628965586210,"gmtModify":1676529900614,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897429690","repostId":"2159521376","repostType":4,"repost":{"id":"2159521376","pubTimestamp":1628906786,"share":"https://www.laohu8.com/m/news/2159521376?lang=&edition=full","pubTime":"2021-08-14 10:06","market":"us","language":"en","title":"Chasing Tesla: Here are the current electric vehicle plans of every major car maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2159521376","media":"MarketWatch","summary":"At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles ","content":"<p>At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes that EVs can shift from niche to normal.</p>\n<p>EVs accounted for 2.4% of U.S. cars sold in 2020, up from 0.7% five years ago, according to BloombergNEF. The research provider expects that share to increase to 11% in 2025; by 2030, it expects that slightly over a third of vehicles sold in the U.S. will be electric.</p>\n<p>Several auto makers had already announced bigger EV ambitions even before the White House call.</p>\n<p>Here are each major car maker's stated plans for EVs, including, when available, investment amounts and the range of models they hope to bring to market.</p>\n<p>This information was collated from company sites, previous reports, and BloombergNEF projections, and will be updated regularly.</p>\n<p><b>Audi</b></p>\n<p>Audi, a brand known for its luxury cars and owned by Germany's Volkswagen AG , has promised to have battery-electric vehicles comprise 35% of its sales by 2025. By that time, Audi buyers will choose from about 20 EV models.</p>\n<p><b>BMW</b></p>\n<p>BMW AG , a luxury-car maker from Germany, was among the first EV innovators. It launched its i3 compact EV eight years ago, then as $one of the few serious competitors to Tesla Inc.'s vehicles.</p>\n<p>BMW's EV pipeline has slowed, but the auto maker has promised that 25% of its European sales will be all-electric and hybrid vehicles this year, and that all sales of its Mini brand will be battery electric by 2030. It expects to launch more than 10 battery EVs models in the next couple of years.</p>\n<p><b>Daimler/Mercedes-Benz</b></p>\n<p>Mercedes-Benz, owned by Daimler AG , expects that between 15% and 25% of its sales will be comprised of EV sales by 2025; by 2030, that percentage is expected to grow to 50%. Mercedes-Benz is slated to end 2021 offering three new electric passenger car models and more to come in 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ec4b2abd59e5b19c9eec0034342af25e\" tg-width=\"700\" tg-height=\"413\" width=\"100%\" height=\"auto\"><span>SOURCE: MERCEDES</span></p>\n<p><b>Ford</b></p>\n<p>Ford Motor Co. <a href=\"https://laohu8.com/S/F\">$(F)$</a> has said that 40% of its global sales by 2030 will be sales of EVs . Ford is aiming to have dozens of electrified models by 2022, the year that will also mark the debut of its much-awaited all-electric F-150 Lightning pickup truck.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3a44fec36dac046911679a2ba769cb2b\" tg-width=\"700\" tg-height=\"450\" width=\"100%\" height=\"auto\"><span>The Ford F-150 Lightning o JEFF KOWALSKY/AGENCE FRANCE-PRESSE/GETTY IMAGES</span></p>\n<p>Ford has called the Lightning the \"pillar\" of its more than $22 billion bet on EVs, which includes EV models for other best-selling vehicles such as the Mustang and its Transit van.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/87df52ddef1af1d1342d685897e83652\" tg-width=\"700\" tg-height=\"392\" width=\"100%\" height=\"auto\"><span>SOURCE: FORD</span></p>\n<p><b>GM</b></p>\n<p>General Motors Co. <a href=\"https://laohu8.com/S/GM\">$(GM)$</a> surprised Wall Street in January by saying it aims to phase out all of its internal combustion engine vehicles by 2035 and only sell zero-emission vehicles by then. The auto maker also promises to be carbon-neutral by 2040.</p>\n<p>GM has said that it will offer 30 all-electric models globally by mid-decade, and that 40% percent of the company's U.S. models will be battery electric vehicles by the end of 2025. Its Hummer electric is expected for next year, with production starting this fall.</p>\n<p><b>Honda</b></p>\n<p>The Japanese maker (7267.TO), which owns the namesake Honda brand and also the luxury-car brand Acura, is projected to derive 40% of its sales from EVs and fuel-cell electric cars by 2030. In April 2020, Honda and GM announced a partnership to develop Honda electric cars using GM's Ultium batteries.</p>\n<p><b>Hyundai</b></p>\n<p>The Korean car maker , which also owns Kia, is aiming to have 40% of its Kia and Hyundai brands sales to be of EVs and fuel-cell electric vehicles by 2025. Its Hyundai brand plans on more than 30 electric passenger vehicles by then.</p>\n<p><b>Mazda</b></p>\n<p>Mazda plans to offer 5% of its vehicles as battery electric by 2030, but EV sales targets as a percentage of total sales are unknown at the moment. Mazda does not offer EVs in the U.S., but sells a few EV and hybrid models elsewhere.</p>\n<p><b>Nissan</b></p>\n<p>Nissan Motor Co. Ltd. was among the first auto makers to offer an all-electric vehicle, and its the Nissan Leaf for years was one of the few options available for those without the deep pockets needed for a Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> Model S.</p>\n<p>Nissan plans to offer 20 EV models in China by next year, and for the U.S. the company recently said it plans that more than 40% of its U.S. vehicle sales by 2030 will be fully electric.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5cbdfabce43725b3d966cf5db5b820f6\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>The Nissan Leaf NISSAN</span></p>\n<p><b>Porsche</b></p>\n<p>The car maker and almost synonym of sports cars is aiming to have half of its sales be of EV vehicles by 2025.</p>\n<p><b>Stellantis</b></p>\n<p><a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> (STLA.MI), the global auto maker formed earlier this year through the merger of Fiat Chrysler Automobiles NV and France's PSA Group, said in July it was investing $35 billion in EVs and adjacent technologies through 2025.</p>\n<p>By that year, Stellantis is expected to derive 31% of its U.S. sales and 38% of its European sales from EVs, percentages that are seen growing to 35% of U.S. sales and 70% of European sales by 2030.</p>\n<p><b>Subaru</b></p>\n<p>The Japanese maker is expected to derive 40% of its sales from EVs and hybrid electric vehicles by 2030.</p>\n<p><b>Toyota</b></p>\n<p>Some 70% of sales for the world's No. 1 car maker (7203.TO) are expected to come from EVs and fuel-cell electric vehicles by 2030. Toyota plans to offer 15 battery EV models by 2025. The car maker, of course, broke ground with its hybrid Toyota Prius two decades ago.</p>\n<p><b>Volkswagen</b></p>\n<p>The car maker is expected to derive 70% of its European sales from EVs and 50% of its U.S. sales from EVs by 2030. Volkswagen has pledged to spend about $40 billion through 2025 on EVs.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chasing Tesla: Here are the current electric vehicle plans of every major car maker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChasing Tesla: Here are the current electric vehicle plans of every major car maker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-14 10:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes ...</p>\n\n<a href=\"https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FUJHF":"Subaru Corporation ","HMC":"本田汽车","HYEVF":"Hyundai Elevator Co Ltd.","GM":"通用汽车","NSANY":"日产汽车","VLKAF":"Volkswagen AG","TSLA":"特斯拉","STLA":"Stellantis NV","F":"福特汽车","DDAIF":"戴姆勒汽车","TM":"丰田汽车"},"source_url":"https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159521376","content_text":"At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes that EVs can shift from niche to normal.\nEVs accounted for 2.4% of U.S. cars sold in 2020, up from 0.7% five years ago, according to BloombergNEF. The research provider expects that share to increase to 11% in 2025; by 2030, it expects that slightly over a third of vehicles sold in the U.S. will be electric.\nSeveral auto makers had already announced bigger EV ambitions even before the White House call.\nHere are each major car maker's stated plans for EVs, including, when available, investment amounts and the range of models they hope to bring to market.\nThis information was collated from company sites, previous reports, and BloombergNEF projections, and will be updated regularly.\nAudi\nAudi, a brand known for its luxury cars and owned by Germany's Volkswagen AG , has promised to have battery-electric vehicles comprise 35% of its sales by 2025. By that time, Audi buyers will choose from about 20 EV models.\nBMW\nBMW AG , a luxury-car maker from Germany, was among the first EV innovators. It launched its i3 compact EV eight years ago, then as $one of the few serious competitors to Tesla Inc.'s vehicles.\nBMW's EV pipeline has slowed, but the auto maker has promised that 25% of its European sales will be all-electric and hybrid vehicles this year, and that all sales of its Mini brand will be battery electric by 2030. It expects to launch more than 10 battery EVs models in the next couple of years.\nDaimler/Mercedes-Benz\nMercedes-Benz, owned by Daimler AG , expects that between 15% and 25% of its sales will be comprised of EV sales by 2025; by 2030, that percentage is expected to grow to 50%. Mercedes-Benz is slated to end 2021 offering three new electric passenger car models and more to come in 2022.\nSOURCE: MERCEDES\nFord\nFord Motor Co. $(F)$ has said that 40% of its global sales by 2030 will be sales of EVs . Ford is aiming to have dozens of electrified models by 2022, the year that will also mark the debut of its much-awaited all-electric F-150 Lightning pickup truck.\nThe Ford F-150 Lightning o JEFF KOWALSKY/AGENCE FRANCE-PRESSE/GETTY IMAGES\nFord has called the Lightning the \"pillar\" of its more than $22 billion bet on EVs, which includes EV models for other best-selling vehicles such as the Mustang and its Transit van.\nSOURCE: FORD\nGM\nGeneral Motors Co. $(GM)$ surprised Wall Street in January by saying it aims to phase out all of its internal combustion engine vehicles by 2035 and only sell zero-emission vehicles by then. The auto maker also promises to be carbon-neutral by 2040.\nGM has said that it will offer 30 all-electric models globally by mid-decade, and that 40% percent of the company's U.S. models will be battery electric vehicles by the end of 2025. Its Hummer electric is expected for next year, with production starting this fall.\nHonda\nThe Japanese maker (7267.TO), which owns the namesake Honda brand and also the luxury-car brand Acura, is projected to derive 40% of its sales from EVs and fuel-cell electric cars by 2030. In April 2020, Honda and GM announced a partnership to develop Honda electric cars using GM's Ultium batteries.\nHyundai\nThe Korean car maker , which also owns Kia, is aiming to have 40% of its Kia and Hyundai brands sales to be of EVs and fuel-cell electric vehicles by 2025. Its Hyundai brand plans on more than 30 electric passenger vehicles by then.\nMazda\nMazda plans to offer 5% of its vehicles as battery electric by 2030, but EV sales targets as a percentage of total sales are unknown at the moment. Mazda does not offer EVs in the U.S., but sells a few EV and hybrid models elsewhere.\nNissan\nNissan Motor Co. Ltd. was among the first auto makers to offer an all-electric vehicle, and its the Nissan Leaf for years was one of the few options available for those without the deep pockets needed for a Tesla Inc. $(TSLA)$ Model S.\nNissan plans to offer 20 EV models in China by next year, and for the U.S. the company recently said it plans that more than 40% of its U.S. vehicle sales by 2030 will be fully electric.\nThe Nissan Leaf NISSAN\nPorsche\nThe car maker and almost synonym of sports cars is aiming to have half of its sales be of EV vehicles by 2025.\nStellantis\nStellantis NV (STLA.MI), the global auto maker formed earlier this year through the merger of Fiat Chrysler Automobiles NV and France's PSA Group, said in July it was investing $35 billion in EVs and adjacent technologies through 2025.\nBy that year, Stellantis is expected to derive 31% of its U.S. sales and 38% of its European sales from EVs, percentages that are seen growing to 35% of U.S. sales and 70% of European sales by 2030.\nSubaru\nThe Japanese maker is expected to derive 40% of its sales from EVs and hybrid electric vehicles by 2030.\nToyota\nSome 70% of sales for the world's No. 1 car maker (7203.TO) are expected to come from EVs and fuel-cell electric vehicles by 2030. Toyota plans to offer 15 battery EV models by 2025. The car maker, of course, broke ground with its hybrid Toyota Prius two decades ago.\nVolkswagen\nThe car maker is expected to derive 70% of its European sales from EVs and 50% of its U.S. sales from EVs by 2030. Volkswagen has pledged to spend about $40 billion through 2025 on EVs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":6,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":262712390664240,"gmtCreate":1705172953608,"gmtModify":1705172955314,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/262712390664240","isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":261024401531064,"gmtCreate":1704737143861,"gmtModify":1704737145573,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/261024401531064","isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259644330790968,"gmtCreate":1704400075658,"gmtModify":1704400077337,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259644330790968","isVote":1,"tweetType":1,"viewCount":36,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258833013289008,"gmtCreate":1704225644605,"gmtModify":1704225646330,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258833013289008","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258113661378616,"gmtCreate":1704050064517,"gmtModify":1704050067598,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258113661378616","isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880058436,"gmtCreate":1631002761325,"gmtModify":1676530439418,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880058436","repostId":"834658219","repostType":1,"repost":{"id":834658219,"gmtCreate":1629800384931,"gmtModify":1676530135097,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834658219","repostId":"1186636161","repostType":4,"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894291102,"gmtCreate":1628826804206,"gmtModify":1676529867502,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>ggood","listText":"<a href=\"https://laohu8.com/S/01810\">$XIAOMI-W(01810)$</a>ggood","text":"$XIAOMI-W(01810)$ggood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894291102","isVote":1,"tweetType":1,"viewCount":129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":260648139239440,"gmtCreate":1704645312299,"gmtModify":1704645315778,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/260648139239440","isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":260353514410184,"gmtCreate":1704573232252,"gmtModify":1704573234105,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/260353514410184","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259985368051992,"gmtCreate":1704483354410,"gmtModify":1704483356628,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259985368051992","isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259264782303448,"gmtCreate":1704309676391,"gmtModify":1704309679670,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259264782303448","isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":258466262950160,"gmtCreate":1704136016885,"gmtModify":1704136019376,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Good good<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>","listText":"Good good<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>","text":"Good good$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/258466262950160","isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":257758733312264,"gmtCreate":1703963279552,"gmtModify":1703963281127,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/257758733312264","isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":257054581284960,"gmtCreate":1703791361988,"gmtModify":1703791363831,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/257054581284960","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":256018878619648,"gmtCreate":1703538857802,"gmtModify":1703538861190,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good hood","listText":"<a href=\"https://ttm.financial/S/BBC\">$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ &nbsp;</a>good good hood","text":"$Virtus LifeSci Biotech Clinical Trials ETF(BBC)$ good good hood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/256018878619648","isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":238301286453248,"gmtCreate":1699214684151,"gmtModify":1699214686849,"author":{"id":"4091812603387580","authorId":"4091812603387580","name":"依然飞飞","avatar":"https://static.tigerbbs.com/78da4bafebf1408f0d799eea86856520","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","listText":"<a href=\"https://ttm.financial/FUND/LU0889565833.HKD\">$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ &nbsp;</a>good good","text":"$FRANKLIN TECHNOLOGY \"A\" (HKD) ACC(LU0889565833.HKD)$ good good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/238301286453248","isVote":1,"tweetType":1,"viewCount":17,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}